Paulo Garcia Email

Co-Founder & Advisor . Kytopen

Current Roles

Employees:
70
Revenue:
$10.8M
About
Kytopen is an MIT startup developing their proprietary Flowfect technology for non-viral delivery of molecules into hard-to-transfect immune cells. The scalable Flowfect technology combines microfluidics and automation to make this process easier, faster, and cheaper than ever before. With our automated cell engineering platform we plan to enable new discoveries in biology that will lead to cost effective cell and gene therapies.
Kytopen Address
750 Main Street
Cambridge, MA
United States
Kytopen Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.